Penumbra’s BMX81 and BMX96 Neuro Access Devices Launched in Europe

June 17, 2024—Penumbra, Inc. announced CE Mark approval and the European launch of the company’s BMX81 and BMX96 devices for neurovascular management of ischemic and hemorrhagic stroke.

According to Penumbra the BMX81 and BMX96 neuro access products are designed to allow physicians to easily navigate the brain’s complex anatomy and can be used from either a femoral or radial access approach.

The devices’ laser-cut stainless steel hypotube provides stability and trackability and allows for a larger inner diameter while maintaining a lower outer diameter, without compromising support. This expands intraprocedural options in both ischemic and hemorrhagic stroke, stated the company.

“I need to be able to trust that my access catheters can provide the stability that I need,” commented Markus Holtmannspötter, MD, in Penumbra’s press release.

Dr. Holtmannspötter, Head of Neuroradiology at Klinikum Nürnberg in Nürnberg, Germany, continued, “The new BMX catheters promise excellent support. With their expanded inner diameters, I will be able to increase therapeutic options for my patients, especially when going radial.”

Penumbra noted that these neuro access products further expand the company’s neuro portfolio in Europe, following the launch of three new Red reperfusion catheters (Red 43, Red 72 with SendIt technology, and Red 78) in May 2024.